A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses

By Somani J.   Lonial S.   Rosenthal H.   Resnick S.   Kakhniashvili I.   Waller E.K.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 221-230

Elsevier

Access to resources Recommend Favorite

Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine

By Asanuma H.   Hirokawa K.   Uchiyama M.   Suzuki Y.   Aizawa C.   Kurata T.   Sata T.   Tamura S.-i.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3981-3989

Elsevier

Access to resources Recommend Favorite

A comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants

By Usinger W.R.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1902-1907

Elsevier

Access to resources Recommend Favorite

Immune responses following cocktails of inactivated measles vaccine and Arachis hypogaea L. (groundnut) or Cocos nucifera L. (coconut) oils adjuvant

By 'Odeh Eghafona N.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1703-1706

Elsevier

Access to resources Recommend Favorite

Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K)

By Watanabe I.   Hagiwara Y.   Kadowaki S.-e.   Yoshikawa T.   Komase K.   Aizawa C.   Kiyono H.   Takeda Y.   McGhee J.R.   Chiba J.   Sata T.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3443-3455

Elsevier

Access to resources Recommend Favorite